Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: A Y1 receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer

Yinjie Wang ab, Zhenqi Jiang ab, Bo Yuan a, Yuchen Tian a, Lingchao Xiang a, Yanying Li ab, Yong Yang c, Juan Li *a and Aiguo Wu *a
aCixi Institute of Biomedical Engineering, CAS Key Laboratory of Magnetic Materials and Devices, & Key Laboratory of Additive Manufacturing Materials of Zhejiang Province, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, P.R. China. E-mail: aiguo@nimte.ac.cn; lij@nimte.ac.cn
bUniversity of Chinese Academy of Sciences, Beijing 100049, China
cDepartment of Clinical Laboratory, the Affiliated Hospital of Medical School of Ningbo University, Ningbo University School of Medicine, Ningbo, 315010, China

Received 18th March 2024 , Accepted 18th March 2024

First published on 22nd March 2024


Abstract

Correction for ‘A Y1 receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer’ by Yinjie Wang et al., Biomater. Sci., 2019, 7, 4748–4757, https://doi.org/10.1039/C9BM00337A.


The authors regret errors in Fig. 3A in the main article and Fig. S18, S19, S20 and S22 in the ESI. These errors occurred when compiling the figures from the raw data.

The correct Fig. 3 is provided here, and the ESI file has been updated with the correct figures.


image file: d4bm90022g-f3.tif
Fig. 3 Fluorescence imaging of AP-NM-IRDye780&Tar in MCF-7/ADR tumor-bearing mice. (A) In vivo fluorescence imaging of tumor-bearing mice before and after the intravenous injection of NM-IRDye780, AP-NM-IRDye780, NM-IRDye780&Tar, and AP-NM-IRDye780&Tar at 6 h (IRDye780: 0.25 mg kg−1). (B) Mean fluorescence intensity (MFI) of tumors at 6 h post-injection. Mean ± SD (n = 3). ** p < 0.01. (C) Ex vivo fluorescence imaging of dissected tumors and main organs at 24 h post-injection. (D) Mean fluorescence intensity (MFI) of the heart, liver, spleen, lungs, kidneys, and tumors. Mean ± SD (n = 3), ** p < 0.01.

An independent expert has viewed the corrected figures and confirmed that they are consistent with the discussions and conclusions presented.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2024